Podcasts about Dip

Dip back into The Fuderation back catalog as we take a look at the 238th episode of WWF Raw is War where Austin would through the IC title in the river.  Originally recorded October 2020.

This week, please join authors John McMurray and David Cherney, editorialist Kausik Umanath, as well as Associate Editors Ian Neeland and Brendan Everett as they discuss the original research articles "Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF" and "Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition" and editorial ""Dip" in eGFR: Stay the Course With SGLT-2 Inhibition." Dr. Carolyn Lam: Welcome to Circulation On the Run, your weekly podcast summary and backstage pass to the Journal and its editors. We're your co-hosts, I'm Dr. Carolyn Lam, Associate Editor from the National Heart Centre and Duke National University of Singapore. Dr. Greg Hundley: I'm Dr. Greg Hundley, Associate Editor and director of the Pauley Heart Center at VCU Health in Richmond, Virginia. Dr. Carolyn Lam: Greg, it's the season of double features. Except this time, we're having a forum discussion of two related articles and an editorial that discusses both. What is it on? SGLT2 inhibitors. In the first paper, an analysis from the DAPA-HF trial, looking specifically at that initial dip in GFR that follows initiation of dapagliflozin in patients with HFrEF. Then we will discuss further, in a mechanistic way, the renal and vascular effects of combining SGLT2 inhibition on top of ACE inhibition. Lots and lots of good learning and insights, but let's go on first to the other papers in today's issue. Shall we? Dr. Greg Hundley: You bet, Carolyn, and I'm going to grab a cup of coffee. Carolyn, in this issue, wow, so many exciting original articles. In fact, there are two more articles that were going to pair together, both clinical and pertaining to TAVR procedures. In the first one, it was a group of authors led by Dr. Duk-Woo Park from the Asan Medical Center at the University of Ulsan College of Medicine. They conducted a multicenter, open-label randomized trial comparing edoxaban with dual antiplatelet therapy or DAPT, aspirin plus clopidogrel, in patients who had undergone successful TAVR and did not have an indication for anticoagulation. Now in this study, Carolyn, the primary endpoint was an incidence of leaflet thrombosis on four-dimensional computed tomography, CT, performed at six months after the TAVR procedure. Key secondary endpoints were the number and volume of new cerebral lesions on brain magnetic resonance imaging or MRI and the serial changes of neurological and neurocognitive function between six months and that time immediately post the TAVR procedure. Dr. Carolyn Lam: Oh, interesting. What did they find? Dr. Greg Hundley: Right, Carolyn. In patients without an indication for long-term anticoagulation after successful TAVR, the incidence of leaflet thrombosis was numerically lower with edoxaban than with dual antiplatelet therapy, but this was not statistically significant. The effect on new cerebral thromboembolism and neurological or neurocognitive function were also not different between the two groups. Now because the study was underpowered, the results should be considered really as hypothesis generating, but do highlight the need for further research. Dr. Greg Hundley: Carolyn, there's a second paper pertaining to transcatheter aortic valve prosthesis. It's led by a group directed by Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation and Abbott Northwestern Hospital. Carolyn, these authors prospectively examined 565 patients with cardiac CT screening for HALT, or what we would define as hypoattenuating leaflet thickening, at 30 days following balloon-expandable and self-expanding TAVR. Now, deformation of the TAVR prosthesis, asymmetric prosthesis leaflet expansion, prosthesis sinus volumes, and commissural alignment were analyzed on the post-procedural CT. For descriptive purposes, an index of prosthesis deformation was calculated, with values greater than 1 representing relative midsegment underexpansion. A time-to-event model was also performed to evaluate the association of HALT with the clinical outcomes. Dr. Carolyn Lam: Oh, interesting. What did they find? Dr. Greg Hundley: Right, Carolyn. Nonuniform expansion of TAVR prosthesis resulting in frame deformation, asymmetric leaflet, and smaller neosinus volume was related to the occurrence of HALT in patients who underwent TAVR. What's the take home here, Carolyn? These data may have implications for both prosthesis valve design and deployment techniques to improve clinical outcomes in these patients. Now, Carolyn, both of these articles are accompanied by an editorial from Dr. Raj Makkar from the Smidt Heart Institute at Cedars-Sinai's Medical Center. It's a very lovely piece entitled Missing Pieces of the TAVR Subclinical Leaflet Thrombosis Puzzle. Well, how about we check what else is in this issue? My goodness, this was a packed issue. First, Carolyn, there are three letters to the editor from Professors Ennezat, Dweck, and then a response from Dr. Banovic pertaining to a follow-up from a previously published study, the AVATAR study, in evaluating valve replacement in asymptomatic aortic stenosis. There's also a Perspective piece from Dr. Wells entitled “Treatment of Chronic Hypertension in Pregnancy: Is It Time For A Change?” There's a Global Rounds piece from Professor Berwanger entitled “Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities.” Then there's also a Research Letter from Professor Eikelboom entitled “Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.” Dr. Carolyn Lam: There's another Research letter by Dr. Borlaug on longitudinal evolution of cardiac dysfunction in heart failure with normal natriuretic peptide levels. There's also a beautiful Cardiology News piece by Bridget Kuehn on the post-COVID return to play guidelines and how they're evolving. Well, that was a great summary of today's issue. Let's hop on to our feature forum. Shall we? Dr. Greg Hundley: You bet, Carolyn. Can't wait. Dr. Carolyn Lam: Today's feature discussion is actually a forum because we have two feature papers in today's issue. They all surround the cardiorenal interaction, should I say, of the SGLT2 inhibitors. For the first paper, discussing that initial decline or that dip in the GFR following initiation of dapagliflozin would be Dr. John McMurray, who's the corresponding author of this paper from DAPA-HF. Dr. John McMurray's from the University of Glasgow. Now next, we have also the corresponding author of another paper, really going into the mechanistic insights of the renal and vascular effects of combined SGLT2 and ACE inhibition. Dr. David Cherney is from Toronto General Hospital, University of Toronto. Dr. Carolyn Lam: We have the editorial list of these two wonderful papers, Dr. Kausik Umanath from Henry Ford Health in Michigan. Finally, our beloved associate editors, Dr. Ian Neeland from Case Western Reserve and Dr. Brendan Everett from Brigham and Women's Hospital, Harvard Medical School. Thank you, gentlemen. Now with all of that, what an exciting forum we have in front of us. Could I start by asking, of course, the respective authors to talk a little bit about your papers? I think a good place to start would be with Dr. McMurray. John, please. Dr. John McMurray: Thanks, Carolyn. I think our paper had three key messages. The early dip in eGFR that we saw was, on average, very small in patients with heart failure, about 3 mLs/min or about 5%. Very few patients had a large reduction in the eGFR. It was around 3%. Dapagliflozin-treated patients had a 30% or greater decline compared to about 1% of placebo patients. Finally, very few of those patients had a decline in the eGFR below a critical threshold, which for cardiologists might be around 20 mLs/min. We saw that in only five patients; that's 0.2% of the dapagliflozin-treated patients. Second message was that that early decline partially reverses. The nadir in our study was about 14 days. But by 60 days, on average, eGFR had increased again. Hold your nerve if you see an early decline in eGFR.   Dr. John McMurray: Maybe the most important message was that that decline in the eGFR is not associated with worse cardiovascular or renal outcomes. In fact, if anything, the opposite. If you look at the patients in the dapagliflozin group with a 10% or greater decline in eGFR, then compare it to patients who didn't have that decline, these individuals were about 27% less likely to experience the primary composite outcome of worsening heart failure and cardiovascular death. If you look at the placebo group, we saw exactly the opposite. Amongst those who had a greater than 10% decline in eGFR compared to those who didn't, those people with the early decline in eGFR were 45% more likely to experience the primary composite endpoint. The same is true for other cardiovascular outcomes for worsening kidney function. In the dapagliflozin group, decline in eGFR was not associated with more adverse events, not associated with more treatment discontinuation. That small decline in the eGFR is not a bad prognostic sign. If anything, it might be the opposite. Dr. Carolyn Lam: Thank you so much. That was really clear. David, are you going to tell us why this decline occurs? Dr. David Cherney: Yeah. Perhaps the paper that we published gives some insights into the mechanisms that are responsible for some of those changes in GFR that are thought to be acute hemodynamic effects. In the between trial, which is the trial that we published examining the effect of ACE inhibition followed by SGLT2 inhibition in patients with type 1 diabetes, we also saw that there was an expected effect of adding SGLT2 inhibition on top of an ACE inhibitor in people with uncomplicated type 1 diabetes. This acute dip in GFR was seen in this cohort of patients. We included only 30 patients in this small mechanistic study. At the same time, along with that dip in GFR, we also saw an increase in measures of proximal natriuresis. That proximal sodium loss is linked with changes in sodium handling in the kidney, which then causes changes in both probably afferent and efferent tone, which causes this dip in GFR primarily through natriuresis in this phenomenon called tubuloglomerular feedback. That was one major observation that gives insight into what we see in larger trials around the dip in GFR. Dr. David Cherney: In our mechanistic study, we also saw an additive effect on blood pressure. Blood pressure went down further with the addition of empagliflozin on top of an ACE inhibitor. In terms of the mechanisms that are responsible for the reduction in blood pressure, natriuresis certainly may be in part responsible, but we also saw a novel observation whereby there was a reduction in peripheral vascular resistance using noninvasive measures. There are likely several mechanisms that are responsible for the reduction in blood pressure. Then finally, we also saw reductions in markers of oxidative stress, which may also account for some of the effects that we see in blood pressure, as well as potentially some of the anti-inflammatory and anti-fibrotic effects that we see at least in experimental models that may have some clinical translatability to humans as well around the clinical benefits. I think the blood pressure, the renal hemodynamic effects, and some of the neurohormonal mechanisms are the major observations that we saw that may in part explain some of the really nice changes that were seen in Dr. McMurray's study. Dr. Carolyn Lam: Right. Thanks, David. But these were patients with type 1 diabetes and no heart failure. John, do you have any reflections or questions about how that may apply? By the way, what a beautiful study. Thank you, David. Dr. David Cherney: Pleasure. Thank you. Dr. John McMurray: Yes, David. I really enjoyed your study. In fact, I think, Carolyn, it does shed some insights perhaps to what's going on. As David pointed out, the reduction in peripheral arterial resistance, reduction in blood pressure, that may play some role in that early dip in eGFR as well as autoregulation in the kidney. Then the other interesting thing is that the distal nephron seems to adapt to that effect in the proximal tubule. Again, that may account for some of that recovery in eGFR, that reversal in the early dip that I spoke about, and which I think is very clinically important because, of course, physicians should make sure that they recheck eGFR if they see that early dip. Because they may find that few weeks later that that dip is much smaller and of much less concern. Dr. Carolyn Lam: Thank you, John. In fact, you're saying, stay the course, right- Dr. John McMurray: I have. Dr. Carolyn Lam: ... with the SGLT2 inhibitors. I'm actually stealing the words of the title of the editorial, a beautiful editorial by Kausik. I love that. Stay the course. Kausik, please, could you frame both papers and then with an important clinical take home message for our audience? Dr. Kausik Umanath: Sure. I think the analysis by John and his group was really relevant with the large sample size. What's impressive? Similar to a lot of these other SGLT2 studies that have come out, both in heart failure and in kidney disease progression and so on, it's remarkable how the other analysis, like the analysis of EMPA-REG and CREDENCE and so on, of similar dips. All show more or less the same magnitude, the same relative proportions of this GFR trajectory. I think the mechanistic study only highlights that though it's working with a slightly different population of type 1 patients and much earlier in their course in terms of where their GFRs are. Dr. Kausik Umanath: The other piece is that ultimately we need to understand this dip and know to monitor for it and so on. But I think the general clinician should really understand that a dip of greater than 10% really occurs in less than half the population that takes these agents. That dip, if it occurs, certainly doesn't do any harm. That said, if they see a bigger dip in the 30% range, monitor more closely and consider making sure that there aren't any other renal issues out there for that patient because they are a much smaller proportion of patients in these large trials that generate that level of dip. They should be monitored. Dr. Kausik Umanath: The other thought that we had, and thinking through this in a practical sense, is because you expect this dip, many of our cardiologists or even the nephrologists when we titrate these drugs, they're on a suite of other drugs. It's probably best to not adjust their Lasix or their loop diuretic, or their RAAS inhibitor at the same time as you're adjusting the SGLT2 inhibitor or starting it because then you may just introduce more noise into the GFR changes that you see over the next several weeks. It may be a sequential piece or at least holding those other agents constant while this gets titrated and introduced is a prudent course of action, so you don't misattribute changes. Dr. Carolyn Lam: Thanks so much. What clinically relevant points. In fact, that point about the diuretic especially applies in our heart failure world. You see the dip. Well, first, make sure the patient's not overdiuresed. Remember, there's more that the patient's taking. Thank you. That was a really great point. Brendan and Ian, I have to get you guys to share your views and questions right now. But before that, can I take a pause with you and just say, aren't you just so proud to be AEs of Circulation when we see papers like these and we just realize how incredible the data are and the clinical implications are? I just really had to say that. All right. But with that, please, what are your thoughts, Brendan? Dr. Brendan Everett: Yeah, sure. Thank you, Carolyn. Hats off to all three of our authors today for doing some amazing science. Thank you for sending it to Circulation. I think, in particular, I handled David's paper. I'm not a nephrologist and I'm probably the furthest thing from a nephrologist. Had to do my best to try and understand these concepts that I'm not sure I ever even was exposed to in medical school many years ago. I think it shows the breadth of the interest in our readership. The fact that these changes in eGFR have become a primary focus for our cardiovascular patients and that the clinical implications are really important. I guess my question, David, is... In your paper, you talked a little bit about this hypothesis of hyperfiltration and the role that hyperfiltration plays in setting patients with diabetes up for kidney disease. Is that playing a role in John's observation or not? Again, as a non-nephrologist, I have trouble connecting the dots in terms of that hypothesis and John's observation of the clinical benefit for patients that have a reduction in eGFR as opposed to no change. Dr. David Cherney: Yeah. It's a great question. It's very difficult to know with certainty in a human cohort because we can't measure the critical parameter, which is intraglomerular pressure, which we think these changes in GFR are a surrogate for. But if we go along with that train of thought, along reductions in glomerular hypertension, it very much makes sense that the patients who dip are those who have the... They're taking their medication, number one. Number two, they respond physiologically in the way that you expect them to, which is that their GFR dips at least transiently and then goes back up again through some of the compensatory mechanisms that John mentioned earlier. As was mentioned not only in this paper, but also in previous analyses from CREDENCE and previous analyses from VERTIS CV and others have shown that indeed that dip in GFR is linked with longer term renal benefits, at least. That is reflected in a reduction in the loss of kidney function over time. Dr. David Cherney: The patients who are on an SGLT2 inhibitor and those who dip by around 10% or less, those patients tend to do the best over time in terms of preserving GFR, not losing kidney function compared to patients who are on an SGLT2 inhibitor but do not dip, or those patients who actually have an increase in GFR. That is consistent with this idea that there may be a reduction in glomerular pressure, which is protective over the long term. That ties back into your question around hyperfiltration that this may indeed be due to a reduction in glomerular pressure, which is linked with risk over the long term. Dr. Carolyn Lam: Ian? Dr. Ian Neeland: I wanted to echo Brendan's comments about the excellent science. When I read these papers, it really speaks to the existential struggle that cardiologists have between kidney function and these medications that we know have cardiovascular benefits. How do we manage that practically? It's so clinically relevant, both the observation that John's paper made about the dip in the DAPA-HF trial as well as, David, your mechanistic insights. Dr. Ian Neeland: I wanted to ask John potentially about the most fascinating aspect to me of this paper was that patients with a dip of 10% or more actually ended up doing better in terms of cardiovascular outcomes, specifically hospital heart failure and hospitalizations than people on placebo with a greater than 10% dip. It speaks to the fact that... Is the physiology going on here different between those individuals whose GFR went down on placebo versus those who are on SGLT2 inhibitors? All the mechanistic insight that David's paper had in terms of blood pressure and intraglomerular pressure, how does that feedback and speak to why heart failure is strongly linked to this mechanism? We see this not just with SGLT2 inhibitors, but there are other medications now coming out showing that there's a relationship between this dip in GFR and heart failure. Can you speak to why this heart failure-kidney connection is so important and becoming greater and greater in terms of our understanding? Dr. John McMurray: Well, thank you for asking me the hardest question and one that I truly don't think I have a good answer to. I think it's obvious to all of us that the kidney is central in heart failure and perhaps cardiologists have neglected that fact, focusing more on the other organ. But by definition, almost the fluid retention that characterizes heart failure in terms of signs, and probably is the primary cause of symptoms, that clearly is a renally-mediated phenomenon. The kidney must be central to all of this. I think David right. I think the decline in eGFR that you see with this drug is simply a marker that the drug is having its physiological effect or effects. Whatever those are, they're beneficial. Clearly, patients who have an eGFR decline on placebo are different and they reflect, again, the patients that we see all the time. As our patients with heart failure deteriorate, one of the things that we commonly see, in fact becomes one of the biggest problems that we have to deal with, is that their kidney function declines. As their symptoms get worse, as their cardiac function gets worse, their kidney function also declines. Dr. John McMurray: I think you're seeing two contrasting effects here. One is the background change in eGFR, which is the placebo patients, and we've always known that that's a bad thing. Then we're seeing that early within 14 days marker of the pharmacological or physiological action of the drug. I hope you don't ask me how SGLT2 inhibitors work in heart failure. That's the other most difficult question I can think of, but I think this is just a marker of the fact that they are working. Dr. David Cherney: Yeah. Just to add to that briefly, there is this difficulty in sorting out the mechanisms that are relevant around the acute effects in the kidney that the dip in GFR reflects natriuresis that could keep patients out of heart failure; that the reduction in glomerular pressure reduces albuminuria. Albuminuria reduction is linked with kidney protection. It's linked with heart failure and ASCVD protection. Then there's also this concept of if you dip and then you stay stable afterwards, your GFR stays stable afterwards, those patients with stable kidney function that's not declining, the dippers in other words, those patients are probably able to maintain salt and water homeostasis better than someone who's declining more rapidly. All these things probably tie together in order to reflect, of course, there's a renal protective effect, but that some of those mechanisms may also tie into the heart failure mechanisms that John was mentioning. Dr. John McMurray: But, David, it's hard to imagine if we don't protect the kidney, we won't protect patients with heart failure given how fundamental, as I said, the kidney is, and how fundamentally important worsening kidney function is. Not only because it is a marker of things going badly, but also because it often results in discontinuation or reduction in dose of other life-saving treatments. To Kausik's point, it was very important about the risk of changing background life-saving disease modifying therapy. Actually, we didn't see that in DAPA-HF, which was very intriguing. There was no reduction in use of renin-angiotensin system blockers or mineralocorticoid receptor antagonists. Dr. Carolyn Lam: Thank you so much, gentlemen. Unfortunately, we are running out of time, but I would really like to ask one last question to the guests, if possible. Where do you think the field is heading? What next? What's the next most important thing we need to know? David, do you want to start? Then John, then Kausik. Dr. David Cherney: I think one of the aspects that we need to know in the future is where else can we extend these therapies into novel indications and extend the boundaries of where we currently work with these therapies. People with type 1 diabetes, for example, with either heart failure or with significant kidney disease, patients with kidney transplantation, is there a renal or cardiovascular protective effect? Then another high risk cohorts who have not been included in trials, those on immunosuppressants, for example, who were excluded from the trials. I think those are some of the areas that we need to extend into now that we understand how these therapies work in even very sick patients and that we also know that they likely have at least some benefit through suppressing inflammation, and possibly reducing infectious risks. That would provide a rationale for extending into some of these new areas. I think that's certainly, hopefully on the horizon for us. Dr. Carolyn Lam: John? Dr. John McMurray: Carolyn, obviously I think looking at post myocardial infarction population, that's an obvious place to go. There are a couple of trials there. I suppose the trial that I would love to see, and which I think would address the core question that we've been discussing today, which is: Is this all about the effect in the kidney and how important is the diuretic and natriuretic action of these drugs in heart failure? I think the key study that would address this would be doing a study in patients on dialysis. Because in those patients we could, I think, separate the issue of natriuresis, diuresis, and maybe even the dip in EGR that we've been talking about. If these drugs prove to be effective in end-stage kidney disease, patients on dialysis, that would be really fascinating. Dr. Carolyn Lam: Kausik? Dr. Kausik Umanath: That is a very interesting point. I don't know that we know necessarily outcomes, but I think from working with the DAPA-CKD, we do have a little bit of the safety data because we did continue it. I was the US MLI for that study and we did continue the SGLT2 passed into renal failure. There is a little bit of safety data there. But I don't think once you've declared an outcome, you're not collecting outcomes data after that point. That's a very interesting area to look into. Dr. Kausik Umanath: I also think the other place where this field's heading is trying to better tier and layer the multitude of agents. I think we've been waiting for about 20 to 30 years, at least in the kidney field, for something new to affect the progression of kidney disease after the ACE/ARB trials and so on. This one we've got SGLT2 inhibitors. We've got the new MRA, finerenone, and so on, which also have very beneficial cardiovascular effects. The question becomes: How do we layer these therapies? Which sequence to go in? Some of the others that are in pipeline as well that are out there that have very beneficial cardiovascular effects that may indeed also help kidney function and diabetes control, which do you go with first and so on? Dr. Carolyn Lam: Wow! Thank you so much. We really could go on forever on this topic, but it has been tremendous. Thank you once again. On behalf of Brendan, Ian, Greg, thank you so much for joining us today in the audience. You've been listening to Circulation On the Run. Don't forget to tune in again next week. Dr. Greg Hundley: This program is copyright of the American Heart Association 2022. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, please visit ahajournals.org.

Today's recipe is The BEST Caesar Salad Dressing and Dip.Here are the links to some of the items I talked about in this episode: #adNinja Blender/Food ProcessorMeasuring CupMeasuring SpoonsChef's KnifeCutting BoardHere's the Recipe Of The Day page with all of our recipe links.If you want to make sure that you always find out what today's recipe is, do one or all of the following:Subscribe to the Podcast,Text the word Dinner to 1-833-413-1352,Join the ROTD Facebook Group here  (this is a brand new group! You'll be a founding member!),Subscribe to get emails here.Have a great day! -Christine xo 

Join me as I speak with Andrew Hale (Bsc, ISCP.Dip.Canine.Prac), the owner, principal trainer and behaviorist at Train Positive in the UK, about emotional awareness and how that applies to dog training.  Both animals and humans have individual emotional care needs. They both need validation, positive reinforcement, and permission to make mistakes. Working with dogs can show us how to be more emotionally available to others. Listen to the episode to learn more about what we can learn from dogs and their emotional experience, switching from a task-oriented approach to a care-oriented approach, and Andrew's acronyms TEA and CAKE! 

Bonus Benson:  Should you stay in touch with your job while you're on vacation? Where was Cookie last week? From Pizza to Dip, Chips and Popcorn, Pickle Is Summer's Big Flavor Cookie's adventure in Times Square last night  Times Square Follow up: How Guy Benson ruined it all!  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of #SFLive, we are speaking with Tavi Costa, Partner & Portfolio Manager at Crescat Capital. We discuss how the current prices of gold & silver, as well as the mining companies, are a gift. What will the FED do next? What impact does the Oil price have? Guest: Tavi Costa, Partner & Portfolio Manager Company: Crescat Capital Twitter: @TaviCosta #SILVER #GOLD Tags: Gold, Gold Price, Finance News, Gold Stocks, Gold Miners, Silver, Silver Price, Silver Squeeze, Silver Investing, Silver Miners, Miners, Mining Stocks, SF Live, Soar Financial, Kai Hoffmann, Gold Stock Investing, How To Invest, Investing in Gold, Investing in Silver, Recession, Silver Market, Silver Mining Stocks, Technical Analysis, Silver Market, Gold Market, Inflation, US Dollar, Buy the Dip, Buying the Dip, Dip Buying, Silver Price Analysis, Tavi Costa, Crescat Capital, Crescat, FED, Interest Rates, Yield Curve Control MAKE SURE TO SUBSCRIBE TO OUR CHANNEL & HIT THE ALERT BUTTON Also, follow us on http://www.twitter.com/soarfinancial - make sure to follow us & click on the bell icon! ►► Follow Us! ◄◄ Twitter: http://twitter.com/soarfinancial Instagram: https://www.instagram.com/soarfinancial/ Facebook: https://www.facebook.com/soarfinancial/ Website: http://www.soarfinancial.com SF Live is a new format by Soar Financial Partners. The goal is to give short company updates and more importantly get investors engaged directly with the companies. Intro Music: "Summer" by Bensound.com **Disclaimer:** Unless specifically disclosed, all information available on Soar Financial and its affiliates or partners should be considered as non-commercial in nature. None of the content produced by Soar Financial should be considered an endorsement, offer or recommendation to buy or sell securities. Soar Financial is not registered with any financial or securities regulatory authority in Canada, the US, Europe, or the UK, and does not provide, nor claim to provide, investment advice or recommendations to any consumer of the content that Soar Financial produces and publicizes. Always do your own due diligence and/or consult a qualified legal, tax, or investment professional if personal advice is deemed necessary. Soar Financial and its related companies (including its directors, employees, and representatives) or a connected person may hold equity positions in securities detailed in communications. When this occurs a disclosure will be made. Disclosures on social media will be made using the hashtag #coi (short for conflict of interest). Soar Financial, its affiliates, and their respective directors, officers, employees, or agents expressly disclaim any liability for losses or damages, whether direct, indirect, special, or consequential, or other consequences, howsoever caused, arising out of any use or reproduction of this site or any decision made or action taken in reliance upon the produced content of Soar Financial, whether authorized or not. By accessing Soar Financial's content, each consumer of Soar Financial content releases Soar Financial, its affiliates, and their respective officers, directors, agents, and employees from all claims and proceedings for such losses, damages, or consequences. Soar Financial may provide content on third-party sites and we disclaim any responsibility for the content of any information posted on such other websites.

Rosenberg and SGG are back from Nashville to break down all the action from ‘SummerSlam.' The guys tell tales from the weekend, and Dip later joins to give his loud takes (17:56). Then, Dip has some strong words for the Street Profits (24:33), Rosenberg gives Bianca Belair some advice, and the guys try to make sense of Ronda Rousey's career path. Plus, Canasta and Dip make a big announcement to the ‘Cheap Heat' universe. Enjoy yourselves. Hosts: Peter Rosenberg, Stat Guy Greg, Dip Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

NEW site: https://www.worldcryptonetwork.com/WCN CLIPS: https://www.youtube.com/channel/UClCE3eOYr4pQ1CTMGZPNt1w/videosWCN MERCH: http://shop.worldcryptonetwork.com/Subscribe to the WCN Audio Podcast on Itunes:https://podcasts.apple.com/us/podcast/the-world-crypto-network-podcast/id825708806----------------------------------------------------------------------------------FeaturingMartijn Wismeijer (https://www.generalbytes.com/en/)Dan Eve (https://twitter.com/cryptopoly)Josh Scigala (https://twitter.com/JScigala)Ben Arc (https://twitter.com/arcbtc)and Thomas Hunt (https://twitter.com/MadBitcoins)THIS WEEK:The quest to find $181 million in bitcoin buried in a dumphttps://www.businessinsider.com/james-howells-threw-away-bitcoin-dump-masterplan-get-back-2022-7Coinbase, Kraken Under Investigation By U.S. Regulators: Reporthttps://bitcoinmagazine.com/legal/coinbase-kraken-face-us-investigationChipotle's ‘Buy the Dip' Promo Includes $200K in Crypto for Customers' Coinbase Accountshttps://decrypt.co/105916/chipotles-buy-the-dip-promo-includes-200k-in-crypto-for-customers-coinbase-accountsReal Anarchists React to ‘The Anarchists,' A New Series About Crypto Broshttps://www.vice.com/en/article/m7gvdp/real-anarchists-react-to-the-anarchists-a-new-series-about-crypto-bros?utm_medium=social&utm_source=motherboardtv_facebook&fbclid=IwAR1fhK8Mr_HtxuGKj1yn_or6MJGlatJdW7r9WcaeB4DcxEr5LokfgZdkm2M&fs=e&s=clMadonna ‘Hellbent' on Buying $1.3M Bored Ape Yacht Club NFT—Now Deemed ‘Too Expensive'https://decrypt.co/106103/madonna-hellbent-on-buying-1-3m-bored-ape-yacht-club-nft-now-deemed-too-expensive______________________________________________World Crypto Networkhttps://www.worldcryptonetwork.com/On This Day in World Crypto Network Historyhttps://www.worldcryptonetwork.com/onthisday/WCN: Hosts & Guestshttps://www.worldcryptonetwork.com/tag/Person/WCN: Topichttps://www.worldcryptonetwork.com/tag/Topic/WCN Clips - YouTubehttps://www.youtube.com/channel/UClCE3eOYr4pQ1CTMGZPNt1w/videosWorld Crypto Network Store | Teespringhttps://teespring.com/stores/world-crypto-network-store-----------------------------------------------------Please Subscribe to our Youtube Channelhttps://m.youtube.com/channel/UCR9gdpWisRwnk_k23GsHfcA

Support Topic Lords on Patreon and get episodes a week early! (https://www.patreon.com/topiclords) Lords: * Hallie * https://twitter.com/Hallie_9000/ * John * https://twitter.com/robohunkx Topics: * Finding value in shared imagined spaces and worlds outside of religious contexts * Final Fantasy Challenge: Zero Story; and other vaporware games & mods of which no record exists on the internet * Youtube streams movies now, and they have comments * Canterbury Tales General Prologue, by Geoffrey Chaucer * https://www.poetryfoundation.org/poems/43926/the-canterbury-tales-general-prologue Microtopics: * The Ten Timers Club. * Podcasting for three years straight. * Fantastical ideas for famous bands covering Garages songs. * An increasingly hard to describe person. * Reclaiming the asshole. * The sort of thing that sometimes happens in Maine. * Finding the right microphone settings. * A podcast about what people think about that ends up being a video game podcast because that's what they're thinking about. * The barnacle on the indie game scene life. * Making a video game good on purpose. * Talking to your friends who talk you out of grad school because you need to be talked out of grad school again * Your own personal relationship with the divine. * Shared imagined worlds and how we talk about them. * Your friend asks how you're doing and you say "Han and Leia at the end of Empire" and your friend just nods. * Fighting a great beast together. * Promoting group cohesion by developing a shared frame of reference. * How in the 70s everyone watched the same three TV channels but nowadays everyone has access to all of every form of media all the time, and whether that's a handicap for developing a shared cultural reference frame. * Waxy potatoes vs. starchy potatoes. * Where to find non-starchy potatoes. * Harry Potter and the Sacred Texts. * The act of interpretation and the creation of shared symbols. * A Final Fantasy mod that you were very excited about in the early 00s but that now has no results on google. * Abraham Lincoln Land vanishing from the internet. * All the bad video games starring Tux. * Your boss saying "let me show you how the Peter Principle works" and promoting you to Project Manager. * Erasing the projects you are ashamed of from your personal web site. * Adding a clause to your will about deleting all your novelty web sites. * A web site where you write a bunch of fake reviews of fake bands and eventually start writing the songs yourself. * Mutually executable languages. * A betrayal of both movies and Youtube. * Commenting with a timestamp of your favorite part of Napoleon Dynamite. * Whether Pedro won the election on his own merits. * Creating an audition tape for the musical extravaganza your employer is running, getting the part, and later finding out that you were the only one who applied. * Whether John will ever release the video of him dancing like Napoleon Dynamite. * An entire stanza of completely unintelligible Middle English. * Wanting to go on pilgrimages to seek the Holy Blissful Martyr because spring is coming. * Pronouncing all the silent letters. * A well-SparkesNotes'd text. * Having a poem memorized but not in order. * How wishing someone a happy birthday before their birthday is illegal in Germany. * The least surfer dude. * Various tobacco saliva receptacles, some of which ding and some of which don't. * Chewing tobacco but not having the self-respect to get a spittoon. * The nicotine delivery method where you stick a tobacco blob under your lip like a walrus tusk and make TikTok videos. * Dip a.k.a. Snus. * A cool friend from Tennessee. * Big League Chew, again. * Asking the clerk for tar patches because nicotine patches don't give you melanoma. * Ending the show early because you believe so vehemently that vaping is good for you. * A pithy German word for having guested on Topic Lords ten times.

Heute machen wir einen Ausflug in Mikas Vergangenheit mit dem Alkohol: Vom ersten Dip in den Bierschaum des Großvaters, über Fruchtbowle mit Björn aus dem Internet, Sangria von der Tanke mit den Punks, Bier in Wacken und Trinkromantik im irischen Pub. Auch das gehört zu einer ganzheitlichen Verarbeitung einer Abhängigkeit dazu: Bevor unsere Unzuverlässigkeit aufhört, cute zu sein, das Alltagstrinken und seine Kollateralschäden schlimmer werden und wir nichtmal mehr unser Pfandmanagement in den Griff kriegen, war das Trinken bei den meisten von uns auch mal ganz kurz ziemlich schön. See acast.com/privacy for privacy and opt-out information.

Today's recipe is Hummus Without Chickpeas.Here are the links to some of the items I talked about in this episode: #adColanderFood ProcessorBlenderMeasuring SpoonsRubber SpatulaHere's the Recipe Of The Day page with all of our recipe links.If you want to make sure that you always find out what today's recipe is, do one or all of the following:Subscribe to the Podcast,Text the word Dinner to 1-833-413-1352,Join the ROTD Facebook Group here  (this is a brand new group! You'll be a founding member!),Subscribe to get emails here.Have a great day! -Christine xo

4th Week of July, 2022 ------

There are many factors to consider when determining the best time to do Roth conversions. Whether you're considering a Roth conversion to meet your future financial goals or simply want to reduce some of your taxable income, here are new episodes that can help you make an informed decision. In this Podcast, Dave talks about… Why are Roth conversions an excellent thing to do? When is the optimal time to do a Roth conversion? Reasons you are probably not a good fit to convert the IRA money Know more about cases based on the tax brackets The difference between pre-tax and Roth Why converting pre-tax 401K IRA dollars to Roth IRAs powerful? Resources Mentioned: Contact: What's My Number? - (612) 284-2409 Blogs The best time to do Roth Conversion What is the super back door Roth Ira? Should I Wait for a Dip?   For all the show notes, and more, check out the podcast website at www.doctorfreedompodcast.com ----more--------more--------more---- Investment advice is only offered in jurisdictions where Centurion Financial Strategies, LLC (“Centurion”) is appropriately registered or exempt from registration. Our Form ADV Part 2 brochure can be obtained free of charge at https://adviserinfo.sec.gov by searching for our firm by name or its unique CRD number (316454). This podcast is not a solicitation to provide advisory services in any jurisdiction in which we are not appropriately registered or excluded from registration. The information, statements, and opinions contained in this podcast have been obtained from or are based upon information obtained from sources which we believe to be reliable, but we do not warrant or guarantee the timeliness or accuracy of any such information. This podcast is intended for informational purposes only and should not be construed as personalized investment, tax, or legal advice. Opinions expressed by any guest are their own opinions and do not necessarily reflect the firm's views. You should carefully consider your unique financial circumstances and needs prior to making any investment in securities or purchasing any insurance products. Past performance is not indicative of future results. Investing in securities involves the risk of loss. Insurance products are backed by the financial strength and claims-paying ability of the issuing insurance company and may be subject to restrictions, limitations, and early withdrawal fees which vary by issuer. You should consider the charges, risks, expenses, and investment objectives of any insurance products before entering a contract.

Social HolidaysJuly 29: Talk in an elevator dayJuly 30: International day of friendshipJuly 31: National Mutt Day, National Avocado DayAugust 1: Respect for parents dayTik Tok NewsKylie Jenner and Kim Kardashian tell Instagram to 'stop trying to be TikTok,'Honda Civic Tour expands beyond live shows with TikTok videos from Future XTrends in the MetaverseMetaverse Real Estate Sales to Grow by $5 Billion by 2026Chipotle's Buy the Dip game will give away $200K in cryptoMarketing News:SoulCycle exchanges used Peloton bikes for in-person classesIf you enjoyed this episode of The Radcast, let us know by visiting our website www.theradcast.com. Check out www.theradicalformula.com. Like, Share and Subscribe to our YouTube channel https://www.youtube.com/c/RadicalHomeofTheRadcast or leave us a review on Apple Podcast. Be sure to keep up with all that's radical from @ryanalford @radicalresults @the.rad.cast @christinaroseyasi @nick_weaver

Minecraft, aka Microsoft, has had enough NFT projects making Millions of dollars on their Minecraft open servers and has banned NFTs... Unless, of course, it's their NFTs in the future. How does this affect projects like NFT Worlds, and what should/are these projects doing now? Ledger has released their very on Genesis Pass NFTs, ripping the Opensea charts; why exactly are they doing so well? Chipotle is back and giving away 200k in Crypto via their new game, "Buy the Dip." Oh... You thought RSG wasn't going to talk about San Diego Comic-Con... you were very wrong. --- Send in a voice message: https://anchor.fm/nerdftradio/message Support this podcast: https://anchor.fm/nerdftradio/support

A lot has happened both personally and professionally that led to some regrettable actions and decisions being made. We always want to be transparent and honest as leaders and today's episode is just that.    Time Stamps:   - Dip in Business and Erin's Father - Going Through Data - Men and Status - These Lessons Apply to Your First Hire - Hashing Out the Issues - Making the Hard Decision - Boat Dock Analogy ---------- IF you're a current online fitness coach, personal trainer, nutritionist, or registered dietitian…  I just recorded a 20-minute training, on how I went from a struggling gym owner and personal trainer barely being able to pay my gym lease…..  To grow my online business to 350k in my first year, 500k in the second, and now my online coaching company generates consistent 7+ figures annually since.    Plus, inside of this training, you'll learn the 4 secrets to building a profitable full-time fitness business that generates consistent 10-30k+ months, all in 90 days or less.   While also unlocking the time + location freedom you DESERVE.    All without sleazy sales tactics, cold DM's, or wasting money on paid advertising.    P.S. It doesn't matter if you have 500 followers, or 100k, this system will WORK for you, as long as you're willing to take action.  Starting RIGHT NOW.    Click the link below, and I'll see you soon.  https://www.impactcoachacademy.com/exclusive-free-training-1 ---------- Imagine Being Able To Walk Away From a 3-Day Mastermind Weekend With the Exact Steps to Start, or Scale Your Fitness Coaching Business + Meet Your New Tribe Who Actually “Get It”   If this sounds interesting… Join Us at the Next Fit Biz Mastermind Weekend - The ONLY live event for fitness coaches that not only teaches you how to increase your income + impact but also will help you eliminate imposter syndrome.  P.S. Use Code FITBIZ2022 For 50% Off Tickets (Limited Time)  To Learn More + Get Your Ticket Before They Sell Out! → CLICK HERE  ---------- Learn More About Impact Fitness Coaching Academy,   To Learn More About I.F.C.A. - And How We've Helped More Than 1,700 Fitness Coaches, Experts, and Influencers Grow a 5-35k+ Month Online Fitness Business Without Paid Ads, Complicated Funnels, or Even Having a Large Social Media Following    Click Here→ to VISIT THE IFCA PAGE  ---------- GIVEAWAY!  Leave a rating + review on iTunes, and Have a Chance To Win a $200 Amazon Gift Card + Special Prizes! Winners Announced Monthly on The Episode. Simply leave a review, and send a screenshot to the Fit Biz Podcast Instagram Page!

On this episode of #SFLive, we are catching up with Patrick Karim aka Badcharts or @badcharts1 on Twitter to discuss possible “buy the dip” scenarios in gold and silver. Guest: Patrick Karim Company: NorthStarBadcharts.com Twitter: @badcharts1 #SILVER #GOLD Tags: Gold, Gold Price, Finance News, Gold Stocks, Gold Miners, Silver, Silver Price, Silver Squeeze, Silver Investing, Silver Miners, Miners, Mining Stocks, SF Live, Soar Financial, Kai Hoffmann, Gold Stock Investing, How To Invest, Investing in Gold, Investing in Silver, Recession, Stagflation, Silver Market, Silver Mining Stocks, Technical Analysis, Silver Market, Gold Market, Inflation, Badcharts, Patrick Karim, US Dollar, Buy the Dip, Buying the Dip, Dip Buying MAKE SURE TO SUBSCRIBE TO OUR CHANNEL & HIT THE ALERT BUTTON Also, follow us on www.twitter.com/soarfinancial - make sure to follow us & click on the bell icon! ►► Follow Us! ◄◄ Twitter: http://twitter.com/soarfinancial Instagram: https://www.instagram.com/soarfinancial/ Facebook: https://www.facebook.com/soarfinancial/ Website: http://www.soarfinancial.com/ SF Live is a new format by Soar Financial Partners. The goal is to give short company updates and more importantly get investors engaged directly with the companies. Intro Music: "Summer" by Bensound.com http://bensound.com/ **Disclaimer:** Unless specifically disclosed, all information available on Soar Financial and its affiliates or partners should be considered as non-commercial in nature. None of the content produced by Soar Financial should be considered an endorsement, offer or recommendation to buy or sell securities. Soar Financial is not registered with any financial or securities regulatory authority in Canada, the US, Europe, or the UK, and does not provide, nor claim to provide, investment advice or recommendations to any consumer of the content that Soar Financial produces and publicizes. Always do your own due diligence and/or consult a qualified legal, tax, or investment professional if personal advice is deemed necessary. Soar Financial and its related companies (including its directors, employees, and representatives) or a connected person may hold equity positions in securities detailed in communications. When this occurs a disclosure will be made. Disclosures on social media will be made using the hashtag #coi (short for conflict of interest). Soar Financial, its affiliates, and their respective directors, officers, employees, or agents expressly disclaim any liability for losses or damages, whether direct, indirect, special, or consequential, or other consequences, howsoever caused, arising out of any use or reproduction of this site or any decision made or action taken in reliance upon the produced content of Soar Financial, whether authorized or not. By accessing Soar Financial's content, each consumer of Soar Financial content releases Soar Financial, its affiliates, and their respective officers, directors, agents, and employees from all claims and proceedings for such losses, damages, or consequences. Soar Financial may provide content on third-party sites and we disclaim any responsibility for the content of any information posted on such other websites.

In the first episode of the post-Vince McMahon era of ‘Cheap Heat,' Rosenberg, SGG, and Dip discuss: McMahon's leaked text message WWE's new leadership structure How the company will change with Triple H as creative director What this move means for AEW Plus, 'SummerSlam' predictions (39:22) and mailbag (56:28)! Hosts: Peter Rosenberg, Stat Guy Greg, Dip Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join me for a mini solo episode where I talk about Life Mountains. Everyone is facing their own challenges whether those are in work, love, health, or life in general, and this week I am hopping on the mic to encourage you to keep climbing. Seth Godin's book The Dip is super relevant here, and I talk about some of the ideas outlined in the book that really helped me determine what/when to quit vs when to keep going. Enjoy! xoxo Nikki Spo Connect with me: www.nikkispo.com @nikkisappspo / @theknowwithnikkispo For info on collabs/sponsorships, please email brands@nikkispo.com. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/nikki-spo/support

It's about time for an addendums episode! AKA an ep where we dump our additional thoughts (and your feedback) on topics we've discussed—because there's always more to say about styling, aging, and, apparently, catalogs.    Looking for a method to define your personal style? Check out Allison Bornstein's Three-Word  Method on TikTok: part 1, part 2, part 3, part 4, part 5, and part 6 for your clicking pleasure. (Call us with your wooords!!) More about her philosophy in this Harper's Bazaar profile.   Re: styling, a follow-up on Amy Smilovic, including the outfit that stopped Claire in her tracks and her shirt-tying innovation. When it comes to button-downs, Claire loves her custom oversize Chava one—it's great with elastic-waist pants (as is this Roucha tank top.)    In response to our discussion of marbling, we learned about some family-owned places to get monogrammed marbled gifts in Florence: Alberto Cozzi and Riccardo Luci.    Speaking of Italy, we both recently visited and fell hard for Milan—it lives up to the promise of Jenny Walton's Instagram and Sight Unseen's Design Week coverage. Keep an eye out for a future Secret Menu installment starring our favorite Milan spots.    Also on the docket: push-up tips, Being Mortal by Atul Gawande for grieving and coping with aging parents, and The Flamingo Estate catalog for zaniness…and as a resource for anyone in L.A. who might want to receive  a bag of manure as a gift.   Share your thoughts with us at 833-632-5463, podcast@athingortwohq.com, or @athingortwohq. And for more recommendations, try out a Secret Menu membership.   Dip into professional counseling with BetterHelp and take 10% off your first month with our link. Refresh your closet with Nuuly. Get $10 off your first month when you sign up with the code ATHINGORTWO10. Support a business of any size with Shopify. Dig in with a free 14-day trial with our link. YAY.   Produced by Dear Media

Have you ever experienced this feeling of wanting to quit? After starting a new business, project or creative venture and now you feel like your questioning whether to give up or keep going? This is the episode for you! Host LDP talks about the concept of "The Dip" coined by author Seth Godin. There is something powerful in understanding when to quit and when to keep going. If you find yourself asking that question lately, tune in to learn more about why quitting, isn't always a bad thing. Find us on Instagram @its_probably_u and our website www.itsprobablyyou.com. Sources: The Dip: A Little Book That Teaches You When to Quit (and When to Stick) by Seth Godin --- Send in a voice message: https://anchor.fm/its-probably-you/message

On today's podcast, Jamie Burton and Lauren Wolverton of the "Chicks and Dip" podcast welcome me on for a conversation about podcasts! We discuss the history of podcasting, what the future of the industry looks like, tips for success, and what makes podcasts stand apart in today's content-filled world (9:20) But before all of that, I update all of you on the CRAZY July I've had (0:00). For more from Jamie and Lauren, subscribe to Chicks and Dip on YouTube. And for some writing from me, please visit troyfarkas.substack.com.

Deepti, Haley and Sarah are back after a bit of time to help you process what has been happening on RHOBH. Diana is terrible. Kyle - OMG KYLE!!! She's being a TERRIBLE self-producer this season. Erika is embarrassing herself so much this season that we almost barely need to talk about her. Garcelle remains a season hero. Sutton...well we need to talk about Sutton. She's complicated (per her own words...eye roll...)(BUT ALSO TRUE???) Deepti also wants to dedicate this podcast (recorded late Friday night July 15th) to her beloved cat, Jonny Bravo Greenwood. JB passed away on July 6, 2022 morning. Deepti loved JB with her entire heart, soul and mind. JB will continue to live on in Dip's heart and will never be forgotten. JB is missed every moment of every day. Deepti watched so much Real Housewives with JB by her side. 

"Heavy Metal is the most conservative of all loud music. Let's face it, not even a gym teacher could get as many people to dress alike."This week on Articulate, Paige Campbell comes on to elaborate on Metal- its history, culture, and transformation into a lifestyle. You ever burn down 30 churches before?? Now that's metal.Dip your toe in, perform some illegal activities, and have a metal week.Music:Metalicious by Alexander Nakarada | https://www.serpentsoundstudios.comMusic promoted by https://www.free-stock-music.comAttribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/ See acast.com/privacy for privacy and opt-out information.

In this episode, Nick talks to Philipp about why you probably need to save less than you think, why you shouldn't fear market volatility, and how to zoom out and gain perspective on market dips. If you enjoy what you've heard, we'd really appreciate it if you'd even consider leaving a quick but thoughtful review. It takes less than 60 seconds, and it really helps us make the show even better for you so that we can convince great guests to join us.Have feedback for us? Is there someone you want us to have on the show? Is there a topic you want covered? Shoot us an email at podcast@stashaway.com. We'd love to hear your thoughts!Find StashAway on FacebookFind StashAway on InstagramFind StashAway on LinkedInFind StashAway on TwitterAlso, our lawyers would want us to tell you that the opinions of our guests are not necessarily shared by StashAway, that past performance is no guarantee of future results, and that what you heard is not investment advice.

Join Judy Luther and Niki Tudge as they chat with Debby Lucken from Kids Around Dogs. KAD - Kids Around Dogs is an award-winning association of Dog Professionals and Child Care Professionals who specialize in helping families with children to train their dogs and live in harmony together. Debby Lucken (ISCP.Dip.Canine.Prac.), the founder of KAD, has also designed a successful protocol to overcome the fear of dogs in kids, which all KAD Approved Members are qualified to use. You can reach Debby here

Are investors acting on the fear of a recession? "The U.S. Dollar has been strong amid a downtrend in the S&P 500 or SPX. Dip buyers came right in after the negative CPI report. Other currencies are struggling and reaching multi-year lows," says Jerry Parker. He also states that investors should love their losses as they can implement new strategies.

Dip back into The Fuderation back catalog as we take a look at the 1996 WWF PPV, Buried Alive.  Originally recorded July 2019.

Seth Godin joins us for the kick-off episode of Season 5 to discuss his new book and project: The Carbon Almanac: It's Not Too Late. For the few who may not know, Seth is an internet pioneer, best-selling author of 20 books, host of the Akimbo podcast and one of the world's most sought-out keynotes speakers. Most importantly Steve was also best man at Seth's wedding.As individuals, citizens and members of the retail community we all have an opportunity and, one could say, an obligation, to address the climate crisis. In a wide ranging conversation we learn what the Carbon Almanac movement is all about, how it came to be and what Seth hopes its impact will be. We go beyond the myth of the "carbon footprint" to delve into the need for true systemic change and how that can be manifested. We also discuss the critical role for the retail industry in demonstrating sustainability leadership and talk about what brands like Patagonia are doing to make a difference.As usual, we kick things off with a fast-paced look into the big retail news of the week, including the need for the industry to "buckle up Buttercup" in the face of growing headwinds,  what to make of Kohl's being left at the alter and what Mark Triton's departure from Bed, Bath & Beyond means from the brand's future. Steve also predicts that some CEO's at digitally native vertical brands might want to update their resumes.Steve's Relevant Forbes ArticlesIs Kohl's New Strategy Merely A Slightly Better Version of Mediocre?Here's Why Amazon Should Buy Kohl's--with One Big CaveatAbout SethSeth Godin is an Author, Entrepreneur and Most of All, A teacherSeth is an entrepreneur, best-selling author, and speaker. In addition to launching one of the most popular blogs in the world, he has written 20 best-selling books, including The Dip, Linchpin, Purple Cow, Tribes, and What To Do When It's Your Turn (And It's Always Your Turn). His book, This is Marketing, was an instant bestseller in countries around the world. The latest book is The Practice, and creatives everywhere have made it a bestseller.Though renowned for his writing and speaking, Seth also founded two companies, Squidoo and Yoyodyne (acquired by Yahoo!).By focusing on everything from effective marketing and leadership, to the spread of ideas and changing everything, Seth has been able to motivate and inspire countless people around the world.In 2013, Seth was one of just three professionals inducted into the Direct Marketing Hall of Fame. In an astonishing turn of events, in May 2018, he was inducted into the Marketing Hall of Fame as well. He might be the only person in both.About UsSteve Dennis is an advisor, keynote speaker and author on strategic growth and business innovation. You can learn more about Steve on his       website.    The expanded and revised edition of his bestselling book  Remarkable Retail: How To Win & Keep Customers in the Age of Disruption is now available at  Amazon or just about anywhere else books are sold. Steve regularly shares his insights in his role as a      Forbes senior contributor and on       Twitter and       LinkedIn. You can also check out his speaker "sizzle" reel      here.Michael LeBlanc  is the Founder & President of M.E. LeBlanc & Company Inc and a Senior Advisor to Retail Council of Canada as part of his advisory and consulting practice.   He brings 25+ years of brand/retail/marketing & eCommerce leadership experience, and has been on the front lines of retail industry change for his entire career.  Michael is the producer and host of a network of leading podcasts including Canada's top retail industry podcast,       The Voice of Retail, plus  Global E-Commerce Tech Talks  ,      The Food Professor  with Dr. Sylvain Charlebois and now in its second season, Conversations with CommerceNext!  You can learn more about Michael   here  or on     LinkedIn. Be sure and check out Michael's latest venture for fun and influencer riches - Last Request Barbecue,  his YouTube BBQ cooking channel!

Eating this with a spoon SOUNDS gross, but have you tried it?

The Break Room (MONDAY 7/11/22) 9am Hour Includes: 1) A large group of sports parents will be making their way to Rochester for a well known sporting event taking place here very soon. Where do they rank on your list of worst sports parents? 2) Eating this with a spoon might sound gross, but have you tried it?

TOPICS AND TIMESTAMPS: Slowdown 0:00 Eyes On the Fed 0:16 Economy Halting 4:19 Don't Buy the Dip 8:31 What To Watch For 10:52 This is not a simple slowdown, this will be much more difficult. If you recognize the patterns in what I will show you today, you will be able to navigate and hopefully prosper. Sound good? Fed minutes June 2022 https://www.cnbc.com/2022/07/06/fed-minutes-june-2022.html https://bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com/public/images/19dafc17-c851-45f1-b783-e41d8ca1e7c9_1000x477.jpeg (1000×477) https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F19dafc17-c851-45f1-b783-e41d8ca1e7c9_1000x477.jpeg recessions more frequent.jpg (721×426) https://cms.zerohedge.com/s3/files/inline-images/recessions%20more%20frequent.jpg?itok=pLdSd7OP private sector capital flows.jpg (1066×1000) https://cms.zerohedge.com/s3/files/inline-images/private%20sector%20capital%20flows.jpg?itok=fBGs9m2z Online Ad Slump Won't Be a Blip for Google, Facebook, Others - WSJ https://www.wsj.com/articles/online-ad-slump-wont-be-a-blip-for-google-facebook-others-11657105381 Supermarkets put security tags on cheese blocks as stores tackle shoplifting amid soaring food costs https://www.msn.com/en-gb/news/uknews/supermarkets-put-security-tags-on-cheese-blocks-as-stores-tackle-shoplifting-amid-soaring-food-costs/ar-AAZeau2 Are widespread layoffs coming? How the pandemic has changed employers' recession strategy https://news.yahoo.com/widespread-layoffs-coming-pandemic-changed-120031683.html 2022-07-06_07-02-02.jpg (896×651) https://cms.zerohedge.com/s3/files/inline-images/2022-07-06_07-02-02.jpg?itok=3bqm6JXs UK new car sales: weakest June since 1996 | Auto Express https://www.autoexpress.co.uk/news/105893/uk-new-car-sales-weakest-june-1996 (1) Tom Hearden on Twitter: "$1 invested in $GE in Q4 1994 is worth $1 today https://t.co/OiJq02mghV" / Twitter https://twitter.com/followtheh/status/1544744863727591425 Petar Momchev on Twitter: "Druckenmiller: "I never use valuation to time the market. I use liquidity considerations and technical analysis for timing. Valuation only tells me how far the market can go once a catalyst enters the picture to change the market direction."" / Twitter https://twitter.com/momchev12/status/1544663585661616134?s=21&t=YodzU7XdulG7RnhrjvEXWQ Macau locks down landmark Lisboa hotel after COVID cases found | Reuters https://www.reuters.com/world/china/macau-locks-down-landmark-lisboa-hotel-after-covid-cases-found-2022-07-06/ Nothing on Horizon to Rival Dollar's Status, Fed Study Finds https://finance.yahoo.com/news/nothing-horizon-rival-dollar-status-131852935.html Consumers Say 2022 Is the Worst Economy Ever - WSJ https://www.wsj.com/articles/consumers-say-2022-is-the-worst-economy-ever-11657103575 Are U.S. Gasoline Refiners Running Out Of Steam? | OilPrice.com https://oilprice.com/Energy/Crude-Oil/Are-US-Gasoline-Refiners-Running-Out-Of-Steam.html Europe Forced To Pay Even Higher Prices To Fill Gas Storage | ZeroHedge https://www.zerohedge.com/commodities/europe-forced-pay-even-higher-prices-fill-gas-storage BW-STATES_Sp22.jpg (1152×1548)

If you don't know who Seth Godin is, just type “Seth” into Google or DuckDuckGo. The first entry will lead you to his blog, where he writes—every day—about marketing, design, writing, how being a better human will make you better at your job. Once you've started to read his blog, you'll probably be hungry for more of his wisdom. He's written over eighteen bestselling books on business and marketing, including Linchpin, Purple Cow, and The Dip. We've been following Seth for a long time, and his writing and speaking have influenced how we think about creating and marketing products. So it was a huge honor to have him on our show, where we spoke about subjects ranging from how to take risks in your career, to why being creative is an act of generosity, to the idea of “creative destruction.” We hope you enjoy our conversation with Seth as much as we did, and after you finish, we encourage you to go make a ruckus.   Takeaways: Why the counterintuitive idea of “surplus” means that, despite everything going on in the world, we all have access to more resources than the last King of France did. Why writing is often the best starting point for almost any type of creative work. Why a company is more like an organism than an organization   Bio Seth is an entrepreneur, best-selling author, speaker and teacher. In addition to launching one of the most popular blogs in the world, he has written 19 best-selling books, including The Dip, Linchpin, Purple Cow, Tribes, and What To Do When It's Your Turn (And It's Always Your Turn). His most recent book, This is Marketing, was an instant bestseller in countries around the world. Though renowned for his writing and speaking, Seth also founded two companies, Squidoo and Yoyodyne (acquired by Yahoo!). By focusing on everything from effective marketing and leadership, to the spread of ideas and changing everything, Seth has been able to motivate and inspire countless people around the world. In 2013, Seth was one of just three professionals inducted into the Direct Marketing Hall of Fame. In an astonishing turn of events, in May 2018, he was inducted into the Marketing Hall of Fame as well. He might be the only person in both. Seth created the altMBA and Marketing Seminar to transform online education and help people connect with their audience.

Dip back into The Fuderation back catalog as we take a look at the Hart family documentary 'Hart & Soul'! Originally recorded for 'Hitman Week' during H&August 2020

In this special live edition of the podcast, 'Cheap Heat' teams up with Wrestling 4 Sale for the heavily anticipated ‘Beers and Schmears.' On today's show, Rosenberg, Stat Guy Greg, and Dip discuss Saturday's ‘Money in the Bank' event, the buildup to 'Summer Slam,' and so much more. Plus, questions from the audience! Hosts: Peter Rosenberg, Stat Guy Greg, Dip Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Pony & Plague talk to our man Toadstool about video games, EH strategy and The Dip. This HIM started The Coop AO and shares the journey to leadership along with how the AO got it's name. We go deep into the topic of Faith and gain some great insight from Toadstool. Grateful for his leadership! Give it a listen

NBA Star Spencer Dinwiddie and former financier Solo Ceesay are putting their heads together to build the new creator economy for Web3.0. Their goal? To empower more meaningful and fulfilling fan experiences. I sat down with them at Consensus to discuss their journey together thus far and what we can expect to see moving forward. We chatted about why Spencer went all in on crypto, why Solo made the switch from Wall Street to the Metaverse, and their newly coined term “Web2.5.” JOIN THE FREE WOLF DEN NEWSLETTER

On today's episode, Rosenberg, SGG, and Dip begin with the biggest MJF story of the week. Then, Dip explains why ‘Forbidden Door' was a “groundbreaking moment” for AEW, which leads to a spirited conversation about the differing paths that WWE and AEW are taking. Plus, ‘Money in the Bank' predictions (31;38), mailbag (43:38), and much more. Are YOU going to be in Las Vegas this weekend? If so, join the guys for the Cheap Heat/Wrestling 4 Sale “Beers and Schmears,” which will include a live podcast, vintage wrestling gear, bagels, beers, and all sorts of schmears. They'll be there from noon to 3 p.m. PT at Tailgate Social. Hosts: Peter Rosenberg, Stat Guy Greg, and Dip Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Rising country artist Josh Ross joins Matt for episode 95! Topics: Dipping vs ZYNGrowing up in CanadaMoving to Nashville Sports to Music Trailer Park BoysFirst Taste of GoneCORE Entertainment Getting thru COVIDFeeling at home in the USUniversal Canada What's to come the rest of the year! For more on Josh give him a follow on IG and TikTok and of course be sure to check out his latest single 'First Taste of Gone'Check out our sponsors!MRL Music GroupSaxman StudiosWhale Tale MediaMitch Wallis 'The Digital Marketing Agency' Be sure to Rate and Subscribe to the podcast

Seth Godin talks about how to give feedback the right way Episode 634: How to Give Feedback by Seth Godin on Critiquing Your Employees as a Business Owner Seth is an entrepreneur, best-selling author, and speaker. In addition to launching one of the most popular blogs in the world, he has written 19 best-selling books, including The Dip, Linchpin, Purple Cow, Tribes, and What To Do When It's Your Turn (And It's Always Your Turn). His most recent book, This is Marketing, was an instant bestseller in countries around the world. Though renowned for his writing and speaking, Seth also founded two companies, Squidoo and Yoyodyne (acquired by Yahoo!). By focusing on everything from effective marketing and leadership, to the spread of ideas and changing everything, Seth has been able to motivate and inspire countless people around the world. In 2013, Seth was one of just three professionals inducted into the Direct Marketing Hall of Fame. In an astonishing turn of events, in May 2018, he was inducted into the Marketing Hall of Fame as well. He might be the only person in both. The original post is located here: https://seths.blog/2006/07/how_to_give_fee/   Visit Me Online at OLDPodcast.com  Interested in advertising on the show? Visit https://www.advertisecast.com/OptimalStartUpDaily Learn more about your ad choices. Visit megaphone.fm/adchoices

Dip into this very special Father's Day episode which is a tapas of papas. Featuring guests Kenyon Martin, Matt Barnes, Master P and Mercy Miller, and Dahntay Jones, each segment is a throwback to some of the best conversations about fatherhood. Stream for free on Hisense Smart TVs, LG Channels, Sports on Tubi, Plex, Samsung TV Plus, The Roku Channel, Vizio Channels fubosportsnetwork.com, and XUMO or as part of fuboTV's subscription packages of 100+ sports, news and entertainment channels. Learn more about your ad choices. Visit megaphone.fm/adchoices

The newly engaged Rosenberg is joined by SGG and Dip to talk about all sorts of news in the world of professional wrestling. On today's episode, the guys discuss the ongoing investigation into Vince MacMahon (11:38) and Sasha Banks's tenuous future with WWE and whether AEW should try to go after her (22:18). The guys also talk about the death of referee Tim White, Randy Orton's injury and its impact on his future, and more. Are YOU going to be in Las Vegas next weekend? If so, join the guys for the Cheap Heat/Wrestling 4 Sale “Beers and Schmears,” which will include a live podcast, vintage wrestling gear, bagels, beers, and all sorts of schmears. They'll be there from noon to 3 p.m. PT at Tailgate Social. Hosts: Peter Rosenberg, Stat Guy Greg, Dip Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dip your toes (Johnjay heard toes... run!) into the latest in Payton's life. You see, Kadeem has a new work schedule and now they are on the same clock! It is ....fabulous...

Matthew McConaughey took over the White House on Tuesday to lecture Americans on guns. It wasn't all bad, but the bad stuff was HORRIBLE! We break it down point by point. Also, pro-abortion extremists are on the rampage, and you won't see it on the news. And the FBI has failed, once again, at stopping pedos. #MatthewMcConaughey #GunControl #GunReform  NEW MERCH! https://crowdershop.com/  GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/show-notes-matthew-mcconaughey Learn more about your ad choices. Visit megaphone.fm/adchoices

The trans community wants to colonize America and normalize women having big penises. Hey, we don't make this stuff up, we are just disgusted by the degeneracy. Also, the Washington Post suspended a reporter for telling a joke. And why you should pay attention to the San Francisco DA recall. #trans #wapo #whatisawoman NEW MERCH! https://crowdershop.com/ GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Drag queens messed with Texas and had a "family-friendly" drag show for little kids over the weekend. Yes, it was gross and was absolute degeneracy. Elsewhere in Texas, we find out a good guy with a gun was STOPPED by police from taking out the Uvalde shooter. And AOC says she's an Indian now. #Uvalde #LGBTQ #PrideMonth NEW MERCH! https://crowdershop.com/ GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Victory is Johnny's! Depp won his defamation suit against Amber Turd — we mean Heard. Let's revel in her misery together! Also, New York is empowering heroin users. And America is sending MORE money to Ukraine. That makes today perfect to kick off CULTURAL APPROPRIATION MONTH, as we salute Russia! #JohnnyDepp #AmberHeard #MeToo NEW MERCH! https://crowdershop.com/  GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Joe Biden invited K-pop group BTS to the White House to address AAPI hate, which is all you need to know about how serious the WH is about addressing AAPI hate. Biden also said more dumb things about guns because it was a day ending in "y." There is also more drama from the Uvalde shooting. And get your rainbow everything out for June! NEW MERCH! https://crowdershop.com/  GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/justin-trudeau-handgun-ban Learn more about your ad choices. Visit megaphone.fm/adchoices

Contrary to what the media says, the Uvalde shooting is a red flag AGAINST gun control. We'll explain why and walk you through the timeline of incompetence. Justin Trudeau is also calling for a ban on all handguns. And Nancy Pelosi's husband drinks too much, but can you blame him? #JustinTrudeau #Uvalde #Handguns NEW MERCH! https://crowdershop.com/ GET TODAY'S SHOW NOTES with SOURCES: https://www.louderwithcrowder.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

We sent a team undercover to infiltrate a Beto O'Rourke campaign rally, and what we found was shocking. After Beto used 19 dead children for a cheap political stunt, today is the perfect time to release it! We're also going deep into the Sussmam trial. SPOILER: Everything Trump said was right! #Beto #Uvadale #GregAbbott  Learn more about your ad choices. Visit megaphone.fm/adchoices